Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Noa Ofir"'
Autor:
Omri Sharabi, Yariv Greenshpan, Noa Ofir, Aner Ottolenghi, Tamar Levi, Leonid Olender, Zachor Adler-Agmon, Angel Porgador, Roi Gazit
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Cancer immunotherapies are highly potent and are gaining wide clinical usage. However, severe side effects require focusing effector immune cell activities on the tumor microenvironment (TME). We recently developed a chimeric antigen recepto
Externí odkaz:
https://doaj.org/article/a8c3491aaadb47f198961624d9339fd6
Autor:
Noa Ofir, Yuval Mizrakli, Yariv Greenshpan, Yftach Gepner, Omri Sharabi, Gal Tsaban, Hila Zelicha, Anat Yaskolka Meir, Uta Ceglarek, Michael Stumvoll, Matthias Blüher, Yoash Chassidim, Assaf Rudich, Anat Reiner-Benaim, Iris Shai, Ilan Shelef, Roi Gazit
Publikováno v:
Bone. 171:116727
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57dd85bea8c85f87de05a24cc382a993
https://doi.org/10.1016/j.bone.2023.116727
https://doi.org/10.1016/j.bone.2023.116727
Autor:
Muhammed Iraqi, Avishay Edri, Yariv Greenshpan, Oron Goldstein, Noa Ofir, Priyanka Bolel, Muhammad Abu Ahmad, Miri Zektser, Kerry S. Campbell, Ory Rouvio, Roi Gazit, Angel Porgador
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4717
Multiple Myeloma (MM) is a devastating malignancy that evades immune destruction using multiple mechanisms. The NKp44 receptor interacts with PCNA (Proliferating Cell Nuclear Antigen) and may inhibit NK cells’ functions. Here we studied in vitro th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4238b56f129717b3f7df598a3c3150ed
Autor:
Omri Sharabi, Yariv Greenshpan, Noa Ofir, Aner Ottolenghi, Tamar Levi, Leonid Olender, Zachor Adler-Agmon, Angel Porgador, Roi Gazit
Publikováno v:
Scientific reports. 12(1)
Cancer immunotherapies are highly potent and are gaining wide clinical usage. However, severe side effects require focusing effector immune cell activities on the tumor microenvironment (TME). We recently developed a chimeric antigen receptor tumor-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c300ad1dff0b7b5f8b1242a529390463
https://pubmed.ncbi.nlm.nih.gov/35504918
https://pubmed.ncbi.nlm.nih.gov/35504918